Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nyxol for Reversal of Pharmacologically-Induced Mydriasis
NCT04620213Phase 3Completed
- Sponsor
- Opus Genetics
- Start
- Nov 2020
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
A Phase 3 trial of phentolamine in Mydriasis, sponsored by Opus Genetics. Started Nov 2020; status: completed.
02
Drugs
phentolamine
03
Conditions
Mydriasis
Beyond the preview
Go deeper on NCT04620213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04620213.